Old Web
English
Sign In
Acemap
>
authorDetail
>
Torbjorn Vik
Torbjorn Vik
AstraZeneca
QT interval
Medicine
Pharmacology
Moxifloxacin
Drug
3
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy Subjects
2016
Clinical Therapeutics
Diansong Zhou
Karen So
Angela W. Dymond
Torbjorn Vik
Nidal Al-Huniti
Gabriella Mariani
Gyorgy Zorenyi
Yifan Huang
Victoria Holmes
Paul Severin
Scott Rasmussen
Paul Martin
Show All
Source
Cite
Save
Citations (3)
Prediction and Modeling of Effects on the QTc Interval for Clinical Safety Margin Assessment, Based on Single-Ascending-Dose Study Data with AZD3839
2014
Journal of Pharmacology and Experimental Therapeutics
Erik Sparve
Angelica Quartino
Maria Lüttgen
Karin Tunblad
Anna Teiling-Gårdlund
Johanna Fälting
Robert Alexander
Jens Kågström
Linnea Sjödin
Alexander Bulgak
Ahmad Al-Saffar
Matthew Bridgland-Taylor
Chris Pollard
Michael D.B. Swedberg
Torbjorn Vik
Björn Paulsson
Show All
Source
Cite
Save
Citations (13)
Early clinical development: Evaluation of drug-induced torsades de pointes risk☆
2008
Pharmacology & Therapeutics
Torbjorn Vik
Chris Pollard
Philip Sager
Show All
Source
Cite
Save
Citations (17)
1